HeartSciences Cash Flow from Operating Activities 2022-2025 | HSCS

HeartSciences cash flow from operating activities from 2022 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
HeartSciences Annual Cash Flow Ops
(Millions of US $)
2024 $-6
2023 $-6
2022 $-4
2021 $-2
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.003B $0.000B
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.685B 52.05
Tempus AI (TEM) United States $8.308B 0.00
Hims & Hers Health (HIMS) United States $6.565B 105.54
Inspire Medical Systems (INSP) United States $4.740B 92.07
IRhythm Technologies (IRTC) United States $3.288B 0.00
Privia Health (PRVA) United States $2.706B 204.09
Enovis (ENOV) United States $2.177B 13.50
Clover Health Investments (CLOV) United States $1.834B 0.00
Omnicell (OMCL) United States $1.635B 35.31
Azenta (AZTA) United States $1.583B 73.70
Phreesia (PHR) United States $1.502B 0.00
Schrodinger (SDGR) United States $1.442B 0.00
10x Genomics (TXG) United States $1.068B 0.00
Butterfly Network (BFLY) United States $0.554B 0.00
Fulgent Genetics (FLGT) United States $0.522B 0.00
Veradigm (MDRX) United States $0.469B 0.00
Talkspace (TALK) United States $0.431B 256.00
TruBridge (TBRG) United States $0.411B 0.00
Standard BioTools (LAB) United States $0.409B 0.00
Claritev (CTEV) United States $0.334B 0.00
Health Catalyst (HCAT) United States $0.318B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
Nyxoah SA (NYXH) Belgium $0.238B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.221B 0.00
American Well (AMWL) United States $0.123B 0.00
EUDA Health Holdings (EUDA) Singapore $0.090B 0.00
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
MDxHealth SA (MDXH) Belgium $0.067B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
CareCloud (CCLD) United States $0.059B 2.53
Zepp Health (ZEPP) China $0.045B 0.00
Outset Medical (OM) United States $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.034B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Movano (MOVE) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Syra Health (SYRA) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00